This report from Life Science Intelligence provides the latest market data for the Global Peripheral Stents Market. Information covered by this report includes:
· unit volumes & pricing forecast from 2019-2024
· analyses of the leading companies, and
· global market share analysis.
The global market for peripheral stents was valued at an estimated $1.1 billion in 2020 and is projected to increase at a CAGR (2020-2024) of 5.7%. Product segments covered by this report include iliac artery stents, biliary stents, tracheobronchial stents.
This report covers the impact of COVID-19 on the peripheral stents market, including a recent forecast from 2020 to 2024. COVID-19 has also impacted leading competitors, such as Abbott, Boston Scientific, Cook Medical, Medtronic, and others. The report provides insights into trends, drivers, and limiters of the peripheral stents market, as well as highlights potential opportunities.
The peripheral stents market was negatively impacted by the COVID-19 pandemic. The pandemic has affected elective surgical procedures markedly, as many non-critical procedures have been cancelled or postponed so that healthcare resources have been conserved for the treatment of COVID-19 and other critically ill patients.
Boston Scientific and Cardinal Health together account for more than 55% of the global market share in the peripheral stents market. The market is expected to witness new entrants with innovative technologies such as Veryan Medical (BioMimics 3D) that have gained FDA clearance. The results of clinical trials in which bioresorbable stents were used to treat peripheral arterial diseases are encouraging and open doors for further clinical research and trials.